Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
cart-19 cells | b-lymphocyte surface antigen b4 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198] Cells[MeSHID:D002477] |
NA | phase 1/2 | unknown |
cart-19 cells | b-lymphocyte surface antigen b4 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Multiple Myeloma[MeSHID:D009101] Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198] Cells[MeSHID:D002477] |
NA | phase 2 | unknown |
cart-19 cells | b-lymphocyte surface antigen b4 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198] Cells[MeSHID:D002477] |
NA | phase 2 | unknown |
cart-19 cells | b-lymphocyte surface antigen b4 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Multiple Myeloma[MeSHID:D009101] Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198] Cells[MeSHID:D002477] |
NA | phase 1/2 | unknown |
cart-19 cells | b-lymphocyte surface antigen b4 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198] Cells[MeSHID:D002477] |
NA | phase 1 | unknown |
cart-19 cells | b-lymphocyte surface antigen b4 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Multiple Myeloma[MeSHID:D009101] Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198] Cells[MeSHID:D002477] |
NA | phase 1 | unknown |
click here to return to the previous page |